The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Structural classification of FOXA1 alterations and their association with clinical outcomes and transcriptional profiles in prostate cancer patients.
 
Jordan Vellky
No Relationships to Disclose
 
Ann Ayzman
No Relationships to Disclose
 
Pornlada Likasitwatanakul
No Relationships to Disclose
 
Aseem Aseem
No Relationships to Disclose
 
Hannah Maluvac
No Relationships to Disclose
 
Weiwei Ma
No Relationships to Disclose
 
Zhengjia Chen
No Relationships to Disclose
 
Karine Tawagi
Honoraria - Binacea; Cardinal Health; Curio Science; GU Oncology Now; IDEOlogy Health; OncLive/MJH Life Sciences; Signify Health
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Seagen
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Mashup Media; Medical Education Consortium; Onc Live; Precisca
 
Steve Kregel
No Relationships to Disclose
 
Justin Hwang
Consulting or Advisory Role - Astrin Bio; Tempus
Research Funding - Astrin Biosciences
 
Donald Vander Griend
No Relationships to Disclose
 
Melissa Reimers
Honoraria - Society of Urologic Nurses and Associates (SUNA)
Consulting or Advisory Role - Astellas Pharma; EMD Serono; Loxo; Pathos AI, Inc
Research Funding - Amgen (Inst); AstraZeneca (Inst); BMS GmbH & Co. KG (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); FORMA Therapeutics (Inst); Genentech (Inst); Janssen (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); ProfoundBio (Inst)
 
Emmanuel Antonarakis
Consulting or Advisory Role - AADi; AIkido Pharma; Amgen; AstraZeneca; Bayer (Inst); Blue Earth Diagnostics; Corcept Therapeutics; Curium Pharma; Foundation Medicine; Hookipa Pharma; Janssen Biotech; Lilly; Menarini Silicon Biosystems; Merck; Pfizer; Sanofi; Tango Therapeutics; Tempus; Z-Alpha
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Merck (Inst); Orion Health (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
 
Natalie Reizine
Consulting or Advisory Role - Curium Pharma; Tempus
Speakers' Bureau - AstraZeneca; EMD Serono; Janssen Oncology; Merck; Tempus